3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Neoplasms
12
Thyroid Cancer, Papillary
5
Adenocarcinoma, Follicular
5
Differentiated Thyroid Cancer
4
Recombinant Human Thyroid Stimulating Hormone
1
Neoplasm Metastasis
1
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
1
Low Risk Differentiated Thyroid Cancer
1
Hypothyroidism
1
Heterotaxy Syndrome
1
Head and Neck Neoplasms
1
DTC - Differentiated Thyroid Cancer
1
Interventions
trametinib
1
dabrafenib
1
Thyrotropin Alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
×
Thyrotropin Alfa
×
Head & Neck
×
Clear all
NCT03244956
2026-03-23
MERAIODE
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
Completed
40 enrolled